Patent · US Expired

Triazolopyrimidine derivatives

US7563781B2 · kind B2 · utility

1Cited by

1References

2Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Donald Ludovici · Quakertown, US
Richard W. Connors · Harleysville, US
Steven J. Coats · McDonough, US
Li Liu · Doylestown, US
Bart De Corte · Southampton, US
Dana L. Johnson · Upper Black Eddy, US
Mark Schulz · Skippack, US

Key dates

Filing date	Jan 11, 2006
Grant date	Jul 21, 2009
Priority date	—
Expiry date	Apr 25, 2026

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/02
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to the discovery of triazolopyrimidine derivatives of formula (I), which have been found to exhibit inhibitory activity against the serine-tyrosine and tyrosine kinases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.